UNSPSC 51284906: Methinamine/sodium salicylate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM550. This VA Drug Class (AM550) classifies this compound as belonging to the group METHENAMINE SALTS ANTIMICROBIALS.

UNSPSC 51284906 Methinamine/sodium salicylate is a Commodity code that sees little relevant recent state and local procurement activity. The code's nominal scope—a specific pharmaceutical compound used historically in urinary antisepsis—does not align with the recent opportunities tagged under it, which solicit naloxone, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through cooperative purchasing frameworks. The mismatch between the code designation and the actual procurements suggests either misclassification by issuing bodies or a shift in how state and local agencies apply this taxonomy to broader pharmaceutical purchasing. State and local health departments, purchasing cooperatives, and emergency-services agencies have tagged pharmaceutical and medical-supply solicitations to this code, but the work being solicited is general pharmaceutical supply and emergency medical equipment rather than methinamine/sodium salicylate specifically.

Recent solicitations include the City of Tampa's IFB for medical and first aid supplies ($700,000 estimated, SLBE set-aside, response due March 13, 2026), Seminole County, Florida's IFB for naloxone and drug deactivation systems (1,900 units annually, quarterly deliveries, response due July 26, 2023), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (March 26, 2026 response deadline, two-year term), and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (April 3, 2026 response deadline, market-intelligence phase). Activity spans health departments and emergency-services divisions in Florida, Texas, Minnesota, and other states participating in cooperative purchasing vehicles, but the volume and geographic concentration do not support a pursue recommendation under this code without verification that the actual need matches methinamine/sodium salicylate specifications.